Oncolytics Biotech
ONCY
#10284
Rank
HK$0.41 B
Marketcap
HK$3.20
Share price
-7.21%
Change (1 day)
-61.57%
Change (1 year)

EPS for Oncolytics Biotech (ONCY)

EPS in 2023 (TTM): -HK$2.62

According to Oncolytics Biotech 's latest financial reports the company's current EPS (TTM) is -HK$2.17. In 2022 the company made an earnings per share (EPS) of -HK$2.63 an increase over its 2021 EPS that were of -HK$3.05.

EPS history for Oncolytics Biotech from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$2.62-0.56%
2022-HK$2.63-13.63%
2021-HK$3.05-5.18%
2020-HK$3.21-64.61%
2019-HK$9.0843.39%
2018-HK$6.33-7.73%
2017-HK$6.86-3.95%
2016-HK$7.143.91%
2015-HK$6.87-48.87%
2014-HK$13.45-33.01%
2013-HK$20.07-42.77%
2012-HK$35.0715.19%
2011-HK$30.456.95%
2010-HK$28.4731.48%
2009-HK$21.65-25.46%
2008-HK$29.05-31.96%
2007-HK$42.70-297.48%
2006HK$21.62-0.74%
2005HK$21.78-193.48%
2004-HK$23.30-243.05%
2003HK$16.2957.79%
2002HK$10.32-15.01%
2001HK$12.15-201.36%
2000-HK$11.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eli Lilly
LLY
HK$242.09-11,269.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.45-1,735.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
-HK$95.85 4,321.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-HK$16.07 641.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$4.94-327.97%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
-HK$6.59 203.97%๐Ÿ‡บ๐Ÿ‡ธ USA